Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.24 | 0.2 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |